Clover Health Investments, Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLOV research report →
Companywww.cloverhealth.com
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers.
- CEO
- Andrew Toy
- IPO
- 2020
- Employees
- 570
- HQ
- Franklin, TN, US
Price Chart
Valuation
- Market Cap
- $1.86B
- P/E
- -32.92
- P/S
- 0.84
- P/B
- 5.52
- EV/EBITDA
- -30.56
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 18.39%
- Op Margin
- -2.57%
- Net Margin
- -2.58%
- ROE
- -17.08%
- ROIC
- -15.76%
Growth & Income
- Revenue
- $1.92B · 40.34%
- Net Income
- $-85,549,000 · -98.91%
- EPS
- $-0.17 · -93.62%
- Op Income
- $-85,529,000
- FCF YoY
- -307.21%
Performance & Tape
- 52W High
- $3.92
- 52W Low
- $1.58
- 50D MA
- $2.33
- 200D MA
- $2.54
- Beta
- 2.45
- Avg Volume
- 6.29M
Get TickerSpark's AI analysis on CLOV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Edwards Carladenise Armbrister | sell | 67,160 |
| May 16, 26 | THORNTON JOSEPH CLAY | other | 16,942 |
| May 13, 26 | Priest Brady Patrick | sell | 98,039 |
| May 8, 26 | Toy Andrew | other | 85,704 |
| Apr 18, 26 | Priest Brady Patrick | other | 36,113 |
| Apr 15, 26 | Priest Brady Patrick | other | 15,471 |
| Apr 15, 26 | Soares Karen | other | 10,161 |
| Apr 15, 26 | Toy Andrew | other | 60,765 |
| Apr 15, 26 | THORNTON JOSEPH CLAY | other | 4,158 |
| Apr 15, 26 | Reynoso Jamie L. | other | 12,712 |
Our CLOV Coverage
We haven't published any research on CLOV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLOV Report →